ArticleProceedings of the National Academy of Sciences of the United States of America2022

Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.

Young Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.